Narasimhan Mani was named Chief Financial Officer of Scienture Holdings, Inc., effective May 26, 2026. As of November 7, 2026, Scienture Holdings, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on May 29, 2026, naming 1 appointment (Form 8-K, May 29, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Scienture Holdings, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Scienture Holdings, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-05-29. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Scienture Holdings, Inc. files it.
Also on the record for Scienture Holdings, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 14, 2025 | Stake report, Schedule 13G/A, by L1 Capital Global Opportunities Master Fund, Ltd. | — | 5%+ stakes | Source |
| August 20, 2025 | Stake report, Schedule 13G, by Scoggin International Fund Ltd. | 0.01% of the class | 5%+ stakes | Source |
| August 19, 2025 | Stake report, Schedule 13G, by L1 Capital Global Opportunities Master Fund, Ltd. | 5.55% of the class | 5%+ stakes | Source |
| August 1, 2025 | Form D, private offering | $1.30M sold | Form D page | Source |
| December 19, 2024 | Form D, private offering | $3.33M sold | Form D page | Source |
Selling to them or working with them? See who runs Scienture Holdings, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Scienture Holdings, Inc. and the records around it.
Scienture Holdings, Inc. elsewhere on the record
- Form D filing Aug 2025
- Who owns it
Companies that share a holder
- Scoggin International Fund Ltd. also filed stake reports on 1 other company: Energy Vault Holdings, Inc. (Aug 2026)
- L1 Capital Global Opportunities Master Fund, Ltd. also filed stake reports on 42 other companies: Youlife Group Inc. (Nov 2026), INLIF Ltd (Oct 2026), DarkIris Inc. (Oct 2026)
Watch Scienture Holdings, Inc.
Get an email when Scienture Holdings, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Scienture Holdings, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Scienture Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Scienture Holdings, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-05-29 | In | Chief Financial Officer | 2026-05-26 | 8-K, 2026-05-29 |
Who leads Scienture Holdings, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Financial Officer: Narasimhan Mani, appointed, effective 2026-05-26 (filed 2026-05-29).
New leaders reset buying decisions — get the Full Report on Scienture Holdings, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Financial Officer at Scienture Holdings, Inc., with the record behind each one.
Find candidates like Chief Financial Officer at Scienture Holdings, Inc.Every change, in the filing's words
Appointed: Narasimhan Mani, Chief Financial Officer, effective 2026-05-26
Appointment of Dr. Narasimhan Mani as Interim Chief Financial Officer In connection with Mr. Sherb's resignation, the Company appointed Dr. Narasimhan Mani (age 51) to serve as the Company's Interim Chief Financial Officer ("Interim CFO") effective as of May 26, 2026.
- Resignation of Eric Sherb On May 26, 2026, Eric Sherb, the Chief Financial Officer ("CFO") of Scienture Holdings, Inc. (the "Company"), formally resigned his position as CFO and advised the Company that his resignation was due to personal reasons and not a result of any dispute or disagreement with the Company, its management, or its board of directors.
- Dr. Mani has served as a director and the Co-Chief Executive Officer and President of the Company since May 2025.
- In these roles, Dr. Mani has, among others, led, managed, and overseen the Company's operations, including its financial operations such as revenue and expense management, financial planning and analysis, and financial reporting.
- In addition to Dr. Mani's technical pharmaceutical experience, he has served in various financial-focused roles for life sciences companies and holds an MBA in Finance and Marketing from Columbia Business School.
- Prior to joining the Company, Dr. Mani served as the President and Chief Executive Officer for Kesin Pharma Corporation, a specialty pharma company with a focus on commercializing specialty and brand products.
Tools for this story
Each opens in a new tab, filled in for Scienture Holdings, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.